ADL and CONUT for Predicting 1-year Mortality Risk in Older Adults After Hip Fracture
Beijing Tongren Hospital, Capital Medical University
1 other identifier
observational
303
1 country
1
Brief Summary
Hip fracture has a serious impact on the quality of life and even the survival of older adults. The multidisciplinary management of hip fracture has been shown to be effective in improving patient outcome and cost-effective in international studies. As geriatricians and members of a multi-disciplinary team(MDT), we are aware of various scores in predicting the 1-year mortality risk in hospitalized older adults with multimorbidity. However, given the need for a deeper understanding of the preoperative status of elderly patients who were suffering from pain, tension, anxiety, delirium,etc., we hope to explore a simple, quick, objective, and accurate method for assessing the status of elderly patients with hip fractures to predict their survival risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 19, 2023
CompletedFirst Posted
Study publicly available on registry
April 14, 2023
CompletedStudy Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2023
CompletedOctober 31, 2023
March 1, 2023
1 month
March 19, 2023
October 30, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Mortality
After discharge, all enrolled patients were followed-up in an outpatients setting. Survival data were obtained via direct contact with patients or patients' caregiver by their physicians at the hospital , or via telephone interview of their family by dedicated coordinators and investigators. Survival data were obtained via direct contact with patients or patients' caregiver by their physicians at the hospital , or via telephone interview of their family by dedicated coordinators and investigators. Outcomes were recorded.
Calculated from the time of discharge, each patient was followed up 1 year, all-cause death in 1 year after discharge was counted.
Study Arms (2)
Death by 1 y
patients who dieded within 1-year after discharge due to hip fracture surgery
Alive at 1 y
patients who survived 1-year after discharge due to hip fracture surgery
Interventions
Eligibility Criteria
Older adults with unilateral hip fractures who received surgical treatment in our hospital from January 2014 to December 2021 were enrolled.
You may qualify if:
- patients aged ≧65 years old;
- patients diagnosed with hip fracture, including femoral neck fracture, femoral intertrochanteric fracture, and femoral subtrochanteric fracture;
- patients whose injury was within 21 days of presentation.
You may not qualify if:
- patients aged \<65 years old;
- patients with pathological fractures due to tumor metastasis or infection or inherited bone disorder;
- patients with avascular necrosis of femoral head;
- patients with periprosthetic fractures;
- old fracture patients treated more than 21 days from injury;
- patients with severe trauma or fracture in other parts;
- patients and their families who could not bear the surgical risk and are unwilling to receive surgical treatment;
- patients died in hospital.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, 100730, China
Study Officials
- STUDY DIRECTOR
QI LIU
Beijing Tongren Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 19, 2023
First Posted
April 14, 2023
Study Start
October 1, 2023
Primary Completion
November 1, 2023
Study Completion
November 1, 2023
Last Updated
October 31, 2023
Record last verified: 2023-03